meetings

Transcript, Meeting 15 Session 4

DR. GUTMANN: I'm going to get started. Welcome back, everyone.

Date

Wed, 12/18/2013

Transcript, Meeting 15 Session 3

DR. WAGNER: You know, we're waiting for Dan. But I think since, what I am essentially doing in the beginning of this is reading into the record the introductions of our speakers, Dan has seen this in the briefing material. So why don't we go ahead.

Date

Wed, 12/18/2013

Transcript, Meeting 15 Session 2

DR. WAGNER: Commissions seated, I believe our three panelists are ready to go.

DR. GUTMANN: Great.

Date

Wed, 12/18/2013

Transcript, Meeting 15 Session 1

DR. GUTMANN: Good morning, everybody. If I could ask everyone to take his or her seat.

I'm Amy Gutmann, I'm President of the University of Pennsylvania and I'm chair of the Presidential Commission for the Study of Bioethical Issues. I welcome you all and Happy Holidays to everybody, too.

Date

Wed, 12/18/2013

Transcript, Meeting 14 Session 1

            DR. GUTMANN:  Welcome everybody.  It is my great pleasure to welcome members o the Commission and the Commission's staff to the University of Pennsylvania. This is the second meeting we've had here, and this is the first meeting, however, we had in the Smilow Center because when this Commission began several years ago the Smilow Center didn't exist.

          And it not only exists, but it is fully occupied, and it is occupied with work that is obviously relevant to the subject of our Commission.

Date

Mon, 08/19/2013

Transcript, Meeting 14 Session 8

          DR. GUTMANN: Thank you for coming together. This is our roundtable even though it's a square table. It is a table that brings together a group of people who really represent a wide range of what this Commission is going to grapple with as we move forward on the BRAIN Initiative. And I'd like to simply start off the roundtable with a question that I often ask at our roundtable.

Date

Tue, 08/20/2013

Transcript, Meeting 14 Session 7

DR. WAGNER: Our next session will focus on models for integrating science and ethics. And to kick us off we are joined by Doctor Deborah Johnson, the Anne Shirley Carter Olsson Professor of Applied Ethics in the Science, Technology and Society Program at the School of Engineering and Applied Sciences at the University of Virginia.

Date

Tue, 08/20/2013

Transcript, Meeting 14 Session 6

DR. GUTMANN:  Good morning, everybody.  If I could ask everyone to take a seat, I'd really appreciate that, so we could get started.  It's wonderful to see everyone here this morning.  I am Amy Gutmann.  I'm President of the University of Pennsylvania and Chair of the Presidential Commission for the Study of Bioethical Issues.  And I'm really delighted on behalf of myself and our Commission Vice Chair, James Wagner, who is President of Emory University to welcome you back here to the Smilow Center for the second day of our Fourteenth Meeting of our Commission.

Date

Tue, 08/20/2013

Transcript, Meeting 14 Session 5

DR. GUTMANN:  We are ready to do our wrap up session for this afternoon. Appropriately the wrap up session is about some overarching recommendations that span the three contexts.

They are important because incidental findings don't just occur in the clinical, research, and DTC context, and they are not just generated by large scale genetic sequencing, imaging, and testing of biological specimens.

We take to heart where we do not think there is genetic exceptionalism, these are issues that span not only the three contexts but other contexts as well.

Date

Mon, 08/19/2013

Transcript, Meeting 14 Session 4

          DR. WAGNER: All right, we are now turning to the third and final, direct to consumer. Anita, thank you for chairing that sub group and we’re interested to hear the report.

Date

Mon, 08/19/2013

Pages

Subscribe to RSS - meetings